Lumida
/FENC
⌘K
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc

FENC
$10.50USD↑+0.57%+0.06 today

MARKET CAP

364.7M

P/E (TTM)

—

FWD P/E

20.1x

DAY RANGE

$10 – $11

52W RANGE

$6
$11

AI Summary

Stalk
StalkMedium

FENC remains in a high-confidence Stage 2 advancing uptrend with an active momentum breakout confirming medium-term bullish structure, but price is currently extended above rising EMAs with overbought RSI and options score, making short-term execution unfavorable; deferred entries on a healthy pullback into support are advised.

  • ↑Q1 2026 net product sales rose 73% YoY to $15.1M
  • ↑Generated positive cash flow in Q1; holds $40.1M in cash
  • ↓Profitability remains weak; Q1 operating expenses hit ~$14M
Full analysis →
Insider Trades26 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Mar 26, 2026BuyFENCChristiana Marie CioffiChief Strategy Officer4,700$4.23$364.7M-7.16%+85.84%$19.9K+3.23%—Stalk
Mar 26, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER13,072$5.10$364.7M-7.16%+85.84%$66.7K+1.25%—Stalk
Feb 18, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER2,450$4.08$364.7M-7.16%+85.84%$10.0K+0.24%—Stalk
Jan 23, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER10,000$2.45$364.7M-7.16%+85.84%$24.5K+0.98%—Stalk
Jan 15, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER10,000$2.45$364.7M-7.16%+85.84%$24.5K+0.98%—Stalk
Jan 7, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER14,184$2.45$364.7M-7.16%+85.84%$34.8K+1.40%—Stalk
May 22, 2025BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER8,220$5.10$364.7M-7.16%+85.84%$41.9K+0.82%—Stalk
May 16, 2025BuyFENCJeffrey S. HackmanChief Executive Officer15,000$6.97$364.7M-7.16%+85.84%$104.6K+1449.28%—Stalk
Nov 18, 2024BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER15,816$2.45$364.7M-7.16%+85.84%$38.7K+1.98%—Stalk
Aug 1, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.25$364.7M-7.16%+85.84%$15.2K-1.28%—Stalk
Jul 2, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.13$364.7M-7.16%+85.84%$14.9K-1.28%—Stalk
Jun 3, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.76$364.7M-7.16%+85.84%$16.4K-1.28%—Stalk
May 1, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$9.11$364.7M-7.16%+85.84%$22.2K-1.28%—Stalk
Apr 19, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,890$5.82$364.7M-7.16%+85.84%$517.1K+0.00%—Stalk
Apr 17, 2024BuyFENCAdrian HaighCHIEF OPERATING OFFICER44,444$2.31$364.7M-7.16%+85.84%$102.7K+200.00%—Stalk
Apr 17, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,888$6.04$364.7M-7.16%+85.84%$536.7K-8.43%—Stalk
Apr 15, 2024BuyFENCAdrian HaighCHIEF OPERATING OFFICER44,444$2.31$364.7M-7.16%+85.84%$102.7K+200.00%—Stalk
Apr 15, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,888$6.30$364.7M-7.16%+85.84%$559.8K-8.09%—Stalk
Apr 4, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER88,583$10.82$364.7M-7.16%+85.84%$958.7K-11.51%—Stalk
Apr 3, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER40,584$10.78$364.7M-7.16%+85.84%$437.5K-6.56%—Stalk
Mar 26, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER13,975$10.90$364.7M-7.16%+85.84%$152.3K-13.22%—Stalk
Mar 25, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER13,975$11.00$364.7M-7.16%+85.84%$153.7K-11.67%—Stalk
Jan 4, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER30,000$10.53$364.7M-7.16%+85.84%$315.8K-10.55%—Stalk
Dec 28, 2023BuyFENCRosty RaykovCHIEF EXECUTIVE OFFICER12,196$4.58$364.7M-7.16%+85.84%$55.8K+0.58%—Stalk
Nov 8, 2023SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER25,044$7.76$364.7M-7.16%+85.84%$194.3K-4.19%—Stalk
Nov 3, 2023BuyFENCRosty RaykovCHIEF EXECUTIVE OFFICER74,793$1.59$364.7M-7.16%+85.84%$118.9K+4.09%—Stalk